Pharmacotherpay of Schizophrenia Flashcards

1
Q

What are the key features that define psychotic disorders?

A

Delusions,hallucinations,disorganized thinking and speech,disorganized or abnormal motor behavior,negative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are delusions?

A

fixed false beliefs that are not amenable to change even with conflicting evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are hallucinations

A

perception-like-experiences that occur without an external stimulus (usually auditory but can also be visual tactile or olfactory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is disorganized thinking and speech

A

switching from one topic to another unrelated to answers to questions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Disease course in schizophrenia.

A

onset late adolescence to early adulthood
men late teens early 20s
women late 20s early 30s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SZ link to substance use?

A

smoking is associated with induction of 1A2 not due to nicotine but because of hydrocarbons produced and inhaled which decreases the serum concentration of 1a2 substrate antipsychotics (olanzapine,asenapine,clonapine,loxapine)
marijuana cocaine and amphetamine use can hasten the onset and exacerbate symptoms and reduce time to relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antipsychotic drug selection

A

oral antipsychotic drug therapy is generally considred first line unless the patient presents with reasons to consider IM depot drug therapy first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are typical antipsychotics?

A

older agents primarily D2 antagonists efficacy for positive symptoms is similar to atypical antipsychotics
Haloperidol,Chlorpromazine Fluphenazine,Perphenazine,loxapine, thioridazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are typical antipsychotic clinical pearls?

A

Halloperidol is most commonly used-routine and PRN
More EPS with high potency drugs)
are very effective for treating the positive symptoms but are likely to worsen negative and cognitive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are Partial Agonists

A

Stabilize dopamine transmission not too much not to little, associated with more akathisia than other antipsychotic.approved for adjunct tx in depression so all have boxed warning for suicidal thoughts and behaviors
aripiprazole, brexpiprazole and cariprazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is aripiprazole?

A

partial agonists 2D6 and 3A4 substrate moderate akathisia low weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is Brexpiprazole?

A

partial agonists, 2D6 and 3A4 substrate moderate akathisia low moderate weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Cariprazine?

A

3A4 substrate moderate akathisia low-moderate weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the “pines”

A

have less D2 antagonism more 5HT2A antagonist Asenapine (Saphris®), Clozapine (Clozaril®),Olanzapine (Zyprexa®) Quetiapine (Seroquel®)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Quetiapine (Seroquel®)?

A

3A4 substrate
QTc prolongation Weight gain and sedation
Boxed warning for suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Olanzapine (Zyprexa®)

A

1A2 substrate
Significant weight gain and sedation
High risk metabolic syndrome
DRESS warning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is Clozapine (Clozaril®)

A

1A2 substrate
Boxed warnings:neutropenia, orthostasis,bradycardia, syncope, seizures, myocarditis, cardiomyopathy
Side effects: sedation,weight gain, constipation,hypersalivation, dry mouth, GI hypomotility with obstruction risk
QTc prolongation
monitoring timelines weekly x 6 months biweeklyx 6 months then every 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is Asenapine (Saphris®)

A

Sublingual and patch formulations, UGT and 1A2 substrate reduce dose of patch if given with strong 1A2 inhibitorsQTc prolongation, apply one patch every 24 hours rotate patch to minimize site reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is Samidorphan

A

added to mitigate weight gain and metabolic syndrome potential of olanzapine it is an opioid antagonist with preferential activity at the mu opioid receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the dones

A

Iloperidone, lurasidone, ziprasidone, risperidone and paliperidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is Iloperidone (Fanapt®)

A

High risk for orthostasis and syncope QTc prolongation, 2D6 substrate

22
Q

what is Lurasidone (Latuda®)

A

3A4 substrate, Higher risk for akathisia, Warning for suicidal thoughts adjunct for bipolar depression Take with food (350 calories) to increase bioavailability

23
Q

what is Ziprasidone (Geodon®)

A

QTc prolongation (contraindication)
DRESS warning
Take with food to increase absorption and bioavailability
3A4 substrate (1/3) and aldehyde oxidase (2/3) (less worry for P450 interactions)

24
Q

what is Risperidone (Risperdal®)

A

D6 substrate (minor 3A4 substrate) EPS, hyperprolactinemia, weight gain,
sedation, orthostasis

25
Q

What is Paliperidone (Invega®)

A

Renally eliminated – dose adjustments in renal
impairment
Similar side effects with risperidone
QTc prolongation

26
Q

what is lumateperone (caplyta)

A

primarily 5HT2A antagonism with post synaptic D2 blockade
Low risk for weight gain or metabolic side effects
Low risk for EPS or akathisia 3A4 substrate

27
Q

What is Pimavanserin (nuplazid)

A

Antipsychotic medication that is FDA-approved for
the treatment of hallucinations or delusions in a patient with Parkinson’s Disease
inverse agonist and antagonist at the serotonin (5HT) 2A and (to a lesser extent) 2C receptors
3A4 substrate

28
Q

Xanomeline/ Trospium (Cobenfy®

A

M1/M4 agonist, 2D6 substrate,Baseline and continued monitoring: LFTs, heart
rate

29
Q

Warnings for all Antipsychotics (except xanomeline/trospium)

A

Boxed Warning: Increased risk of death in elderly patients treated with antipsychotics for dementia with related behaviors.
Metabolic adverse effects
EPS
Risk of somnolence, postural hypotension, and motor and/or sensory instability increases the risk for falls/fractures.
Fall risk assessment should be performed for patients taking other medications or having other disease states that also have a fall/fracture or somnolence/hypotension risk; assess when initiating antipsychotic and repeat routinely if on continuous long-term treatment

30
Q

What is haloperidol

A

Given every 4 weeks
Load: 20 times oral dose
Maintenance: 10 times oral dose
If only use maintenance, may
need oral overlap
Oil-based – Z-track

31
Q

Risperdal® Consta (risperidone)

A

MUST supplement with oral risperidone (or another oral antipsychotic) for the first few weeks of treatment – I tell providers until 3rd injection (week 4)

32
Q

what is Rykindo® (risperidone)

A

Every 2 week IM injection, Oral dose overlap is shorter than Risperdal
Consta (7 days vs 21 days)

33
Q

what is Perseris® (risperidone)

A

Every 4 week LAI dosage form of risperidone, Abdominal subcutaneous injection, 3A4 inducers – use 120 mg dose or may need oral supplementation

34
Q

What is Uzedy® (risperidone)

A

Abdominal or upper arm subcutaneous injection, Given once monthly or every 2 months

35
Q

What is Invega®
Sustenna (paliperidone)

A

Loading dose, then booster, then every 4 weeks (starting 5 weeks
after loading injection),Initial loading and booster doses must be given in deltoid to
improve absorption consistency, If loading strategy followed, no need for oral overlap antipsychotic treatment,May require dose adjustment in moderate to severe renal
impairment

36
Q

Invega® Trinza (paliperidone q3mo)

A

May be initiated for a patient who has been on a stable monthly (every 4 week) IM
injection of Invega Sustenna (only way that it should be used), at least FOUR
stable Invega Sustenna doses Recommended to be given deltoid; gluteal administration results in a lower Cmax Not recommended if CrCl < 50 mL/min

37
Q

Invega® Hafyera (paliperidone q6mo)

A

May be initiated after stable Invega Sustenna for 4 months or stable Invega Trinza after one 3- month dose Gluteal injection only

38
Q

Zyprexa® Relprevv (olanzapine)

A

REMS, DSS – post-dose delirium sedation syndrome
Oral 10mg once daily, 15mg once daily,20mg once daily
IM Depot 210mg IM every 2 weeks, 405mg IM every 4 weeks, 300mIM every 2 weeks

39
Q

Abilify® Maintena (aripiprazole)

A

MUST overlap with oral aripiprazole (or another oral antipsychotic) for at least 14 days after first injection
Deltoid or gluteal injection

40
Q

Abilify® Maintena – Dose Adjustments for P450 Interactions

A

Patients Taking 400mg of Abilify Maintena
300mg Strong CYP 2D6 OR CYP 3A4 Inhibitors
200mg CYP 2D6 AND CYP 3A4 Inhibitors
Avoid Use CYP 3A4 Inducers

Patients Taking 300mg of Abilify Maintena
200mg Strong CYP 2D6 OR CYP 3A4 Inhibitors
160mg CYP 2D6 AND CYP 3A4 Inhibitors
Avoid Use CYP 3A4 Inducers

41
Q

Abilify® Asimtufii (aripiprazole)

A

Every-2-month dosing
Gluteal injection only continue oral aripiprazole for 2 weeks after first injection

42
Q

Aristada® (aripiprazole lauroxil)

A

Overlap with oral aripiprazole for 3 weeks after first injection unless Aristada Initio given first

43
Q

Aristada Initio

A

Developed to avoid need for 21-day oral overlap of antipsychotic
Avoid in patients who are 2D6 poor metabolizers or with strong 3A4 or 2D6 inhibitors

44
Q

immediate Release Antipsychotic Injections/ Psychiatric Emergencies

A

Haloperidol, chlorpromazine, fluphenazine are used,
haloperidol most commonly, Olanzapine immediate release IM – CANNOT be given
at the same time as a benzodiazepine immediate release
injection – boxed warning for respiratory depression
Loxapine for inhalation (Adasuve®)

45
Q

Clinical Treatment Strategies for EPS

A

Acute Dystonia;IM anticholinergic NOW dose (benztropine 2mg, diphenhydramine
50mg)
Drug-Induced Parkinson’s:Oral anticholinergic (benztropine, trihexyphenidyl, diphenhydramine)
Akathisia:Beta-blocker – propranolol preferred first-line - ~
Benzodiazepine – usually lorazepam
Tardive Dyskinesia:VMAT inhibitors

46
Q

what are VMAT inhibitors

A

Tetrabenazine (Xenazine® Valbenazine (Ingrezza®) Deutetrabenazine (Austedo®)

47
Q

Valbenazine (Ingrezza®)

A

2D6/3A4 substrate
Side effects: QTc prolongation

48
Q

Deutetrabenazine (Austedo®)

A

2D6 substrate
Side effects: QTc prolongation,

49
Q

Neuroleptic Malignant Syndrome

A

Life- threatening – IS a medical emergency
Hyperpyrexia, tachycardia, labile blood pressure
Muscle rigidity – elevated (significantly) CK,
myoglobinuria
Treatment is supportive
Future antipsychotic use is NOT contraindicated

50
Q

Metabolic Adverse Effects

A

Hyperglycemia, hyperlipidemia, hypertension
clozapine = olanzapine >
quetiapine = risperidone = paliperidone = asenapine =
iloperidone = cariprazine = brexpiprazole >
ziprasidone = lurasidone = aripiprazole